Liver dysfunction resulting from Xianlinggubao capsules in 2 cases

Yang Yiheng,Zhou Yanli

DOI: https://doi.org/10.3969/j.issn.1008-5734.2007.03.029

2007-01-01

Abstract:Two patients developed liver dysfunction after treatment with Xianlinggubao capsules for osteoporosis. The first patient, a 65-year-old woman with hypertension and cerebral insufficiency, was treated with Jiangyalinghao and ginkgo biloba leaf tablets. And then her regimen was added to Xianlinggubao capsules 1.5g twice daily. Six months later, laboratory inves- tigations revealed ALT and AST levels of 85 U/L and 93 U/L, respectively. Xianlinggubao capsules were stopped, and Jiangyalinghao and ginkgo biloba leaf tablets were continued. After 20 months of cessation of Xianlinggubao capsules, her ALT and AST levels decreased to 17 U/L and 28 U/L, respectively. The second patient, a 68-year-old woman with atrophic gastritis, was receiving a long-term therapy with cisapride. And then her regimen was added to Xianlinggubao capsules1.5g twice daily. Two months later, laboratory tests showed following values: ALT 158 U/L and AST 123 U/L. Xianlinggubao capsules were discontinued, and cisapride was continued. In addition, the patient was administered with glucurolactone 200 mg thrice daily for 15 days. Approximately 6 months later, her ALT was 35 U/L and AST was 23 U/L.